Cite
Turkalj M, Banic I, Anzic SA. A review of clinical efficacy, safety, new developments and adherence to allergen-specific immunotherapy in patients with allergic rhinitis caused by allergy to ragweed pollen (. Patient Prefer Adherence. 2017;11:247-257doi: 10.2147/PPA.S70411.
Turkalj, M., Banic, I., & Anzic, S. A. (2017). A review of clinical efficacy, safety, new developments and adherence to allergen-specific immunotherapy in patients with allergic rhinitis caused by allergy to ragweed pollen (. Patient preference and adherence, 11247-257. https://doi.org/10.2147/PPA.S70411
Turkalj, Mirjana, et al. "A review of clinical efficacy, safety, new developments and adherence to allergen-specific immunotherapy in patients with allergic rhinitis caused by allergy to ragweed pollen (." Patient preference and adherence vol. 11 (2017): 247-257. doi: https://doi.org/10.2147/PPA.S70411
Turkalj M, Banic I, Anzic SA. A review of clinical efficacy, safety, new developments and adherence to allergen-specific immunotherapy in patients with allergic rhinitis caused by allergy to ragweed pollen (. Patient Prefer Adherence. 2017 Feb 14;11:247-257. doi: 10.2147/PPA.S70411. eCollection 2017. PMID: 28243068; PMCID: PMC5317300.
Copy
Download .nbib